| Project Title |
Principal Investigator(s) |
| A Systems Biology Approach to Identify Novel Mechanisms Linking Epigenetic Regulation, Cell Proliferation, Tumor Progression and Aging |
Lori Pile, Ph.D.
Ahmad Heydari, Ph.D. |
| Accuracy of the CancerGene Program to Estimate the Probability of a BRCA1/2 Mutation: Effect of Limited Family Structure |
Michael Simon, M.D. |
| Are Observational Coding Systems of Trust in Breast Oncology Interactions Culturally Sensitive? |
Donyell Coleman, Ph.D.
Sharon Mills-Wisneski, DNSc
Kelly Brittain, M.S.N. |
| DCE-MRI Imaging to Monitor Vascular Changes and Therapeutic Efficacy Induced by Combined Modalities for Murine Renal Cell Carcinoma |
Gilda Hillman, Ph.D.
Mark Haacke, Ph.D. |
| Lung Cancer and Bone Metastases |
Shirish Gadgeel, M.D.
Fulvio Lonardo, M.D. |
| Modulation of inducible regulatory T cells (iTreg) in cancer immunotherapy |
Venuprasad Poojary, Ph.D.
Wei-zen Wei, Ph.D. |
| Non-invasive Assessment of Tumor Cell Viability In Vivo |
Rod Braun, Ph.D.
Bruce Berkowitz, Ph.D. |
| Oncogene Profiling of Lung Cancers: Insight into the leading cause of cancer deaths |
Michele Cote, Ph.D.
Ramsi Haddad, Ph.D. |
| Patient Determinants of Non-Adherence to Phase II and III Oral Cancer Therapy |
Felicity Harper, Ph.D.
Louis Penner, Ph.D.
Elisabeth Heath, M.D. |
| Prostate Cancer Proteasome as a Novel Molecular Target of Metal Complexes: Synthesis and Biological Validation in vitro and in vivo |
Claudio Verani, Ph.D.
Q. Ping Dou, Ph.D. |
| Protease Signaling on the Cell-Surface of Breast Cancer Cells: Role of Matriptase Mediated Activation of the Proto-Oncogene c-Met |
Julie Boerner, Ph.D.
Karin List, Ph.D. |
| Roles of Endoplasmic Reticulum Factor ERLIN2 in Malignancy Maintenance and Therapy Resistance in Breast Cancer |
Zeng-Quan Yang, Ph.D.
Kezhong Zhang, Ph.D. |
| Synthetic Genetic Interactions & Cancer Therapy |
George Brush, Ph.D.
Russell Finley Jr., Ph.D. |
| The Cancer Palmitoyl-Proteome |
Nicholas Davis, Ph.D.
Raymond Mattingly, Ph.D. |
| The Potential for Therapeutic Targeting Malignant Pleural Mesothelioma with PCFT-targeted cytotoxins |
Larry Matherly, Ph.D.
John Graff, Ph.D. |
| The Role of Iroquis homeobox gene 4 in Breast Cancer Tumorigenesis and Metastasis |
Guojun Wu, Ph.D. |
